MARKET

GKOS

GKOS

Glaukos Corp
NYSE
116.64
+0.46
+0.40%
Pre Market: 116.64 0 0.00% 04:08 12/26 EST
OPEN
116.38
PREV CLOSE
116.18
HIGH
117.94
LOW
116.20
VOLUME
6
TURNOVER
0
52 WEEK HIGH
163.71
52 WEEK LOW
73.16
MARKET CAP
6.70B
P/E (TTM)
-75.2176
1D
5D
1M
3M
1Y
5Y
1D
S&P 500 Futures Flat In Premarket Trading; United Therapeutics, Intel Lag
Dow Jones · 1d ago
Glaukos Is Maintained at Buy by UBS
Dow Jones · 2d ago
UBS Maintains Buy on Glaukos, Raises Price Target to $145
Benzinga · 2d ago
Glaukos price target raised to $145 from $140 at UBS
TipRanks · 2d ago
Weekly Report: what happened at GKOS last week (1215-1219)?
Weekly Report · 3d ago
Glaukos Is Maintained at Buy by Truist Securities
Dow Jones · 12/18 14:37
Glaukos price target raised to $145 from $120 at Truist
TipRanks · 12/18 14:17
Seaport Research healthcare analyst holds analyst/industry conference call
TipRanks · 12/17 21:16
More
About GKOS
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.

Webull offers Glaukos Corp stock information, including NYSE: GKOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GKOS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GKOS stock methods without spending real money on the virtual paper trading platform.